Application of Nanoparticle Technologies in the Combat against Anti-Microbial Resistance

被引:85
作者
Kumar, Mayur [1 ]
Curtis, Anthony [1 ]
Hoskins, Clare [1 ]
机构
[1] Keele Univ, Inst Sci & Technol Med, Sch Pharm, Keele ST5 6DB, Staffs, England
关键词
anti-microbial resistance; anti-bacterial modality; drug carriers; nanoparticles; oxidative stress; STAPHYLOCOCCUS-AUREUS; ANTIBACTERIAL ACTIVITY; SILVER NANOPARTICLES; PSEUDOMONAS-AERUGINOSA; GOLD NANOPARTICLES; ZNO NANOPARTICLES; BIOFILM FORMATION; OXIDE; BACTERIA; IRON;
D O I
10.3390/pharmaceutics10010011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Anti-microbial resistance is a growing problem that has impacted the world and brought about the beginning of the end for the old generation of antibiotics. Increasingly, more antibiotics are being prescribed unnecessarily and this reckless practice has resulted in increased resistance towards these drugs, rendering them useless against infection. Nanotechnology presents a potential answer to anti-microbial resistance, which could stimulate innovation and create a new generation of antibiotic treatments for future medicines. Preserving existing antibiotic activity through novel formulation into or onto nanotechnologies can increase clinical longevity of action against infection. Additionally, the unique physiochemical properties of nanoparticles can provide new anti-bacterial modes of action which can also be explored. Simply concentrating on antibiotic prescribing habits will not resolve the issue but rather mitigate it. Thus, new scientific approaches through the development of novel antibiotics and formulations is required in order to employ a new generation of therapies to combat anti-microbial resistance.
引用
收藏
页数:17
相关论文
共 90 条
[21]   Mechanistic Study of the Synergistic Antibacterial Activity of Combined Silver Nanoparticles and Common Antibiotics [J].
Deng, Hua ;
McShan, Danielle ;
Zhang, Ying ;
Sinha, Sudarson S. ;
Arslan, Zikri ;
Ray, Paresh C. ;
Yu, Hongtao .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2016, 50 (16) :8840-8848
[22]   Newer antibacterial drugs for a new century [J].
Devasahayam, Gina ;
Scheld, William M. ;
Hoffman, Paul S. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (02) :215-234
[23]   Innovation in the pharmaceutical industry: New estimates of R&D costs [J].
DiMasi, Joseph A. ;
Grabowski, Henry G. ;
Hansen, Ronald W. .
JOURNAL OF HEALTH ECONOMICS, 2016, 47 :20-33
[24]   Biofilms: Microbial life on surfaces [J].
Donlan, RM .
EMERGING INFECTIOUS DISEASES, 2002, 8 (09) :881-890
[25]   Reactive Oxygen Species Mediated Bacterial Biofilm Inhibition via Zinc Oxide Nanoparticles and Their Statistical Determination [J].
Dwivedi, Sourabh ;
Wahab, Rizwan ;
Khan, Farheen ;
Mishra, Yogendra K. ;
Musarrat, Javed ;
Al-Khedhairy, Abdulaziz A. .
PLOS ONE, 2014, 9 (11)
[26]  
Fomda BA, 2014, INDIAN J MED RES, V140, P672
[27]   Antimicrobial-resistant bacteria in the community setting [J].
Furuya, EY ;
Lowy, FD .
NATURE REVIEWS MICROBIOLOGY, 2006, 4 (01) :36-45
[28]   Singlet Oxygen Stress in Microorganisms [J].
Glaeser, J. ;
Nuss, A. M. ;
Berghoff, B. A. ;
Klug, Gabriele .
ADVANCES IN MICROBIAL PHYSIOLOGY, VOL 58, 2011, 58 :141-173
[29]   Vancomycin-resistant enterococci: Mechanisms and clinical observations [J].
Gold, HS .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) :210-219
[30]   Alteration of Zeta potential and membrane permeability in bacteria: a study with cationic agents [J].
Halder, Suman ;
Yadav, Kirendra Kumar ;
Sarkar, Ratul ;
Mukherjee, Sudipta ;
Saha, Pritam ;
Haldar, Saubhik ;
Karmakar, Sanmoy ;
Sen, Tuhinadri .
SPRINGERPLUS, 2015, 4 :1-14